UNSPSC 51262601: Atipamezole

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C14H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03N9U5JAF6, chemically known as 1h-imidazole, 4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)- but generally known as atipamezole, which bears US NIH Compound Identifier 71310. European Medicines Agency schedules Atipamezole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05594MIG.

UNSPSC 51262601 Atipamezole is a Commodity code that encompasses pharmaceutical products and medications used in clinical and community health settings. Based on recent state and local solicitations, the code captures procurement of naloxone, drug deactivation systems, and related pharmaceutical supplies that support public health and emergency response initiatives. State and local buyers under this code include county health departments and state health and human services commissions, which source these products to support community health programs, overdose response, and pharmacy benefit management initiatives. Issuing bodies reflect a mix of local health authorities managing direct procurement and state-level HHS agencies coordinating broader pharmaceutical strategy and direct-to-manufacturer contracting relationships.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) posted April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information on direct contracting, negotiated net pricing models, and outcomes-based agreements from vendors with experience serving self-insured employers and government health plans. Recent activity spans Florida and Texas; the code shows limited visibility across state and local jurisdictions, with issuing bodies focused on community health procurement and state-level pharmacy benefit program development rather than broad commodity purchasing.